ADX: JULPHAR Statistics

Total Valuation

Gulf Pharmaceutical Industries P.S.C. has a market cap or net worth of AED 1.49 billion. The enterprise value is 2.38 billion.

Market Cap	1.49B
Enterprise Value	2.38B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Gulf Pharmaceutical Industries P.S.C. has 1.16 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.16B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.69%
Owned by Institutions (%)	0.17%
Float	361.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	129.00
PS Ratio	0.87
PB Ratio	1.99
P/TBV Ratio	2.43
P/FCF Ratio	7.16
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 11.45.

EV / Earnings	-103.68
EV / Sales	1.39
EV / EBITDA	13.07
EV / EBIT	63.76
EV / FCF	11.45

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.41.

Current Ratio	2.26
Quick Ratio	1.27
Debt / Equity	1.41
Debt / EBITDA	5.89
Debt / FCF	5.16
Interest Coverage	0.52

Financial Efficiency

Return on equity (ROE) is -2.75% and return on invested capital (ROIC) is 1.23%.

Return on Equity (ROE)	-2.75%
Return on Assets (ROA)	0.96%
Return on Capital (ROIC)	1.23%
Revenue Per Employee	713,667
Profits Per Employee	-9,583
Employee Count	2,400
Asset Turnover	0.70
Inventory Turnover	1.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+65.39%
50-Day Moving Average	1.35
200-Day Moving Average	1.03
Relative Strength Index (RSI)	47.77
Average Volume (20 Days)	3,225,912

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gulf Pharmaceutical Industries P.S.C. had revenue of AED 1.71 billion and -23.00 million in losses. Loss per share was -0.02.

Revenue	1.71B
Gross Profit	629.40M
Operating Income	37.40M
Pretax Income	-20.00M
Net Income	-23.00M
EBITDA	134.80M
EBIT	37.40M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 190.00 million in cash and 1.07 billion in debt, giving a net cash position of -884.60 million or -0.77 per share.

Cash & Cash Equivalents	190.00M
Total Debt	1.07B
Net Cash	-884.60M
Net Cash Per Share	-0.77
Equity (Book Value)	759.90M
Book Value Per Share	0.65
Working Capital	846.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 251.70 million and capital expenditures -43.50 million, giving a free cash flow of 208.20 million.

Operating Cash Flow	251.70M
Capital Expenditures	-43.50M
Free Cash Flow	208.20M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 36.75%, with operating and profit margins of 2.18% and -1.34%.

Gross Margin	36.75%
Operating Margin	2.18%
Pretax Margin	-1.17%
Profit Margin	-1.34%
EBITDA Margin	7.87%
EBIT Margin	2.18%
FCF Margin	12.16%

Dividends & Yields

Gulf Pharmaceutical Industries P.S.C. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.54%
FCF Yield	13.97%

Stock Splits

The last stock split was on May 28, 2020. It was a reverse split with a ratio of 0.5655820688.

Last Split Date	May 28, 2020
Split Type	Reverse
Split Ratio	0.5655820688

Scores

Gulf Pharmaceutical Industries P.S.C. has an Altman Z-Score of 1.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.49
Piotroski F-Score	n/a